SCHEMBL6135730

SCHEMBL6135730

Cc1nc(O)n[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30033075 0.67
SCHEMBL30404460 0.67
SCHEMBL18922264 0.65
SCHEMBL18922258 0.65 AOC3 (0.32)
SCHEMBL11965063 0.65
SCHEMBL20003983 0.65
SCHEMBL21935852 0.64 POLB (0.33)
SCHEMBL11211862 0.63
SCHEMBL26114409 0.63 LMNA (0.72)
SCHEMBL14845683 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104317172-A Stripper for stripping photoresist SHENZHEN CAPCHEM TECHNOLOGY CO LTD 2015-01-28 CN claimed
US-11124502-B2 Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (US) 2021-09-21 US disclosed
US-20200283422-A1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2020-09-10 US disclosed
CN-104317172-B A kind of stripper for photoresist lift off 深圳新宙邦科技股份有限公司 2018-12-04 CN disclosed
CN-107608181-A A kind of photoresist lift off stripper for TFT LCD displays 合肥惠科金扬科技有限公司 2018-01-19 CN disclosed
US-20170349574-A1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2017-12-07 US disclosed
US-9801872-B2 Pyridinyl and fused pyridinyl triazolone derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-10-31 US disclosed
CN-107102517-A A kind of AMOLEED display screens remover composition with photoresist 合肥市惠科精密模具有限公司 2017-08-29 CN disclosed
US-9670186-B2 Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (US) 2017-06-06 US disclosed
EP-2882716-B1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP LLC (US) 2016-12-07 EP disclosed
EP-1535499-A1 PROCESS FOR PREPARING A SUBSTANTIALLY TRANSPARENT CONDUCTIVE LAYER CONFIGURATION Agfa-Gevaert (BE) 2005-06-01 EP disclosed
WO-2005030192-A1 4- (1H-INDOL-3-YL-METHYLIDENEAMINOXY-PROPOXY) -BENZIOC ACID DERIVATIVES AND RELATED COMPOUNDS AS PAI-1 INHIBITORS FOR THE TREATMENT OF IMPAIRMENT OF THE FIBRINOLYTIC SYSTEM AND OF THROMBISIS WYETH (US) 2005-04-07 WO disclosed
WO-2005030199-A1 4-(1-BENZOFURAN-3-YL-METHYLIDENEAMINOXY.PROPOXY))-BENZOIC ACID DERIVATIVES AND RELATED COMPOUNDS AS PAI-1 INHIBITORS FOR THE TREATMENT OF IMPAIRMENT OF THE FIBRINOLYTIC SYSTEM AND OF THROMBOSIS WYETH (US) 2005-04-07 WO disclosed
WO-2005030760-A1 SUBSTITUTED HETEROARYL BENZOFURAN ACIDS WYETH (US) 2005-04-07 WO disclosed
WO-2005030702-A1 BIPHENYLOXY-ACIDS WYETH (US) 2005-04-07 WO disclosed
US-20050070592-A1 Substituted phenyl indoles WYETH (US) 2005-03-31 US disclosed
US-20050070592-A1 Substituted phenyl indoles WYETH (US) 2005-03-31 US disclosed
US-20050070584-A1 Substituted aryloximes WYETH (US) 2005-03-31 US disclosed
US-20050070584-A1 Substituted aryloximes WYETH (US) 2005-03-31 US disclosed
WO-2004019666-A1 PROCESS FOR PREPARING A SUBSTANTIALLY TRANSPARENT CONDUCTIVE LAYER CONFIGURATION AGFA-GEVAERT (BE) 2004-03-04 WO disclosed